Perelman School of Medicine

Murray Grossman, MD, EdD, a professor of Neurology in the Perelman School of Medicine at the University of Pennsylvania and director of Penn’s Frontotemporal Degeneration (FTD) Center, recently received the Legal Clinic for

Lee-Ann Donegan ・December 31, 2015

Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer-induced weakness in the patient’s immune system – a weakness that in principle could be corrected with a HER2-targeted vaccine – according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Results of the study show that T cells from patien

Katie Delach ・December 30, 2015

Penn Medicine’s Gary Lichtenstein, MD, a professor of Medicine and Gary Wu, MD, the Ferdinand G.

Paul Foster ・December 30, 2015

Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature review and additional original research conducted by experts at the

Steve Graff ・December 30, 2015

Anil K. Rustgi, MD, chief of Gastroenterology in the Perelman School of Medicine at the University of Pennsylvania, is once again the recipient of a prestigious Research Professor Award from the American Cancer Society (ACS).

Lee-Ann Donegan ・December 28, 2015

For the third of all epilepsy patients who don’t respond to medication, an alternative is to locate the small cluster of neurons that act as the seed of a seizure’s aberrant electrical activity and surgically remove it. Unfortunately, such surgeries often fail to bring any relief.

Evan Lerner, Lee-Ann Donegan ・December 17, 2015

The amygdala, a small structure at the front end of the brain’s temporal lobe, has long been associated with negative behaviors generally, and specifically with fear. But new research from Michael Platt, the James S.

Michele W. Berger ・December 14, 2015